Interpretation of rhinoconjunctivitis quality of life questionnaire data.
about
Work-related airway symptoms, nasal reactivity and health-related quality of life in female hairdressers: a follow-up study during exposure.Regular versus as-needed short-acting inhaled beta-agonist therapy for chronic obstructive pulmonary disease.The "physician on call patient engagement trial" (POPET): measuring the impact of a mobile patient engagement application on health outcomes and quality of life in allergic rhinitis and asthma patients.House dust mite-specific immunotherapy with two licensed vaccines: Outcome under clinical routine conditionsThe effects of two Chinese herbal medicinal formulae vs. placebo controls for treatment of allergic rhinitis: a randomised controlled trial.Cost-effectiveness of second-generation antihistamines and montelukast in relieving allergic rhinitis nasal symptoms.From IgE to anti-IgE: where do we stand?A randomised multicentre trial of acupuncture in patients with seasonal allergic rhinitis--trial intervention including physician and treatment characteristicsA systematic review and meta-analysis of probiotics for the treatment of allergic rhinitisThe effect of injection immunotherapy on mucociliary clearance in allergic patients.Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study.Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial.Is there any correlation between the results of skin-prick test and the severity of symptoms in allergic rhinitis?Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study.β-Glucan supplementation, allergy symptoms, and quality of life in self-described ragweed allergy sufferers.Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review.Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper.Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.Acupuncture for persistent allergic rhinitis: a multi-centre, randomised, controlled trial protocolComparison of outcome measures in allergic rhinitis in children, adolescents and adults.Quality of life in adults and children with asthma and rhinitis.Interpreting treatment effects in randomised trialsTian Jiu therapy for allergic rhinitis: study protocol for a randomized controlled trialEconomic Evaluation of Quality-of-Life Improvement with Second-Generation Antihistamines and Montelukast in Patients with Allergic Rhinitis.Impact of Nasal Symptoms on the Quality of Life of Fresh Inductees in High Altitude.Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis.Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis.Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE).In allergic rhinitis, work, classroom and activity impairments are weakly related to other outcome measures.Wraparound eyeglasses improve symptoms and quality of life in patients with seasonal allergic rhinoconjunctivitis.Interpretation of Renal Quality of Life Profile scores in routine clinical practice: an aid to treatment decision-making.Probiotics-impregnated bedding covers for house dust mite allergic rhinitis: A pilot randomized clinical trial.Efficacy of sublingual immunotherapy for house dust mite allergic rhinitis.The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitis.Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.Rhinitis management: the patient's perspective.Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.Off-label use of omalizumab in non-asthma conditions: new opportunities.Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36.
P2860
Q30444647-35925DB6-967B-4D5A-8E1E-8E108615B171Q32032862-CB5C2953-3CF0-41F1-8D3F-6B63E5E5B9F9Q33443203-512D6781-ECBA-40DA-A418-3F45B742739FQ33638751-50A613A4-17DA-46C5-BD64-FCC19761A92EQ33890457-219E0CF7-3CBC-4D8C-AC96-BB8A278BBC8AQ33931982-FB7D83DD-DCA0-4A3F-BAAF-B574AD440BF6Q34929214-D2A7A4B3-1122-47D7-997B-0C61A4DBE7C0Q35141146-42BB2011-3412-4040-B441-A49E8AA69011Q35610964-37E6A0FF-8B2C-48E0-B46B-7547437F34A7Q36198074-B28D73FC-A74E-482F-8660-8DE1A229638FQ36963993-0D01C922-1526-45DE-B60A-B320948979B2Q37057746-762BF46E-24F9-487E-B0D5-749878058C7CQ37530908-986D9E8E-FC84-487D-BDE5-016E966A90A6Q37591378-AB182B71-6BB9-48F1-B7B0-FA566D093A6FQ37633371-EB879C69-AE62-4ADF-B107-5CE83BE71319Q37814445-29F60224-F841-427D-A88B-E57828820215Q38206795-B17382BB-BCEA-48D6-A921-304C37CBB3D2Q39175919-2436A8B8-CA3B-44B0-A1C0-1427AD17210AQ39300939-F2268CFC-C309-408B-ADDE-AFB3E0F07CA9Q39942966-AF9B7CD4-D0F2-4DE3-B743-EE0B845E28BEQ41635294-F76D4958-3640-4ABA-9E76-D20FDD8915A0Q41729509-62F84BCE-0784-437B-9948-02DF72E7BB34Q41986315-93516DCC-3AC7-4197-8574-EB9162AC26C0Q42026758-2EEEC50B-372F-4970-9003-22EC6F32B32DQ42229932-99993A9C-473C-458B-9781-2F73894AB0CDQ44051945-64CEC279-5840-44B8-A454-87CBC3222DD5Q44794327-6F80DFDD-AADA-4C32-BD14-34D91E4DA57DQ44810280-BD39926C-D261-427E-9D25-12D9695A4431Q47632018-153EF304-86A3-4ED1-965A-BA20A8FFF8C6Q47813458-0AA6D240-9C27-403D-B91A-44D2C996A6F1Q47898323-09FEEFCF-04EB-40BE-9C62-7728D214A4EAQ47916962-EE02C40B-AD1F-4934-9F22-596C995B7C44Q48056038-36471E86-E898-44FE-B609-3FC64D6A6214Q48067195-53ADD06E-FF71-4710-9B9A-D9116CDB14DFQ48247434-41A16C38-8E86-4DF9-8A19-9C08CABF68E1Q48771871-5DA97251-9BF6-4B33-ADD6-94F8546F575EQ49075893-0DA39974-168B-45EF-B3DB-FECA9ABEBC59Q50940308-B5C7573A-DD2D-4A64-8C2B-FDF8F51F86B2Q51770958-9C4D6C10-439B-4C36-8D29-733052755FB3Q51958771-78564082-6B9A-431C-BB75-0DBD2909906A
P2860
Interpretation of rhinoconjunctivitis quality of life questionnaire data.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Interpretation of rhinoconjunctivitis quality of life questionnaire data.
@en
type
label
Interpretation of rhinoconjunctivitis quality of life questionnaire data.
@en
prefLabel
Interpretation of rhinoconjunctivitis quality of life questionnaire data.
@en
P2093
P921
P1476
Interpretation of rhinoconjunctivitis quality of life questionnaire data.
@en
P2093
Griffith LE
Juniper EF
P304
P356
10.1016/S0091-6749(96)70135-5
P407
P577
1996-10-01T00:00:00Z